Agilent Life Sciences SS CD GlasgowCancerHaem, 96A
The Agilent SureSelect Custom DNA Glasgow Cancer Haem Panel (part number 5191-6957) is designed for targeted next-generation sequencing (NGS) applications. This panel enables comprehensive analysis of genes associated with cancer and hematological disorders, supporting high-throughput workflows with 96 reactions per kit. Utilizing Agilents SureSelect technology, the panel provides high specificity and uniformity for efficient target enrichment, ensuring reliable detection of relevant genetic variants. The kit is optimized for use with Agilents NGS platforms and is suitable for research applications in oncology and hematology.